1. Introduction {#sec0005}
===============

This work has been reported in line with the SCARE criteria \[[@bib0005]\].

Ampullary adenocarcinoma is a malignant tumor originating from the ampulla of Vater and it accounts for 0.5% of all gastrointestinal (GI) malignancies \[[@bib0010]\]. Ampullary adenocarcinoma is rare entity during pregnancy \[[@bib0015]\]. The best treatment modality for resectable tumors providing the best outcome is a complete surgical resection in the form of pancreaticoduodenectomy (Whipple procedure) \[[@bib0020]\]. Here, we report a case of 22 years old pregnant female at 28th week of gestation and its challenges in diagnosis and management & a review of literature.

2. Case presentation {#sec0010}
====================

We report a case of a 22 years old pregnant female medically free, referred to us from her Obstetrician when she was complaining of abdominal pain and jaundice. Abdominal US confirmed a single intrauterine pregnancy at 28th week of gestation with appropriate growth for date and showed dilated intrahepatic ducts otherwise it was inconclusive due to the gravid uterus ([Fig. 1](#fig0005){ref-type="fig"}). Her blood investigations showed a picture of cholestatic jaundice, and all other labs were within normal. So, we decided to proceed with a Magnetic resonance cholangiopancreatography (MRCP) which showed dilatation of both of the CBD (measuring 0.9 cm) & pancreatic duct, as well as an ampullary mass measuring 2 cm ([Fig. 2](#fig0010){ref-type="fig"}). Later on, Endoscopic retrograde cholangiopancreatography (ERCP) with shielding of the abdomen to protect the fetus from radiation revealed an ampullary and distal CBD strictures. A punch biopsy was taken & the CBD was stented. The histopathology came as invasive adenocarcinoma & full metastatic work up was done and did not reveal any metastatic lesions. So, surgery was the best available option with the best possible outcome but we were reluctant to delay the surgery to ascertain the viability of the fetus. At 34th week of gestation induction of labor was done, both mother and the baby did well and were discharged home on 2nd day postpartum. The mother was readmitted one week later & full body CT scan repeated & there was no vascular invasion or distant metastasis.Fig. 1Fetal Ultrasound showed a healthy fetus.Fig. 1Fig. 2(A--D) MRCP showed dilated common CBD, pancreatic duct, and ampullary mass was 2 cm in size.Fig. 2

Therefore, we proceeded with pancreaticoduodenectomy. A laparotomy incision was done, intraoperative examination of the abdomen revealed; a palpable mass at the ampulla of Vater and the stent was felt in the CBD and duodenum, a bulky uterus as the patient was still in the postpartum period. There was no vascular invasion, peritoneal deposits or any other distant metastasis. For the pancreatojejunostomy anastomosis, a two-layer end-to-side duct-to-mucosa approach was adopted. The pancreatic duct was stented to divert the pancreatic secretions away from the anastomosis. Then the hepaticojejunostomy was done in an end-to-side fashion followed by the gastrojejunostomy.

The Patient had uneventful postoperative course and was discharged 1 week after her surgery. Histopathology came as poorly differentiated invasive adenocarcinoma of ampulla of Vater with negative resection margins. Three out of thirteen lymph nodes revealed metastatic involvement so she received six cycles of adjuvant chemotherapy which she tolerated well. Upon 6 years follow up, computed tomography (CT) and positron emission tomography (PET) scans were normal with no evidence of recurrence.

3. Discussion {#sec0015}
=============

Patients with periampullary tumors can present with wide variety of gastrointestinal symptoms. The most commonly is obstructive jaundice 2ry to CBD obstruction. In other cases, they can present with biliary colic along with constitutional symptoms especially in adenocarcinoma compared to other types of GI malignancies \[[@bib0025]\].

We reviewed published articles concerning periampullary & pancreatic malignant tumors that has been diagnosed during pregnancy & confirmed by histopathology in the English literature. To the best of our knowledge, only 41 cases have been reported ([Table 1](#tbl0005){ref-type="table"}) and our case is the 42nd. Porcel et al. published the first case of adenocarcinoma of ampulla of Vater in pregnant woman at 3rd trimester in 1992 \[[@bib0030]\]. Upon our review (N = 41), the common age of presentation that was found in the literature was during the 30 s in contrast to our case, where the patient presented to us at the age of 22 years old. The most common histopathological type was found to be adenocarcinoma (18 cases), followed by mucinous cystic neoplasm (16 cases), neuroendocrine neoplasms (3 cases), Solid-pseudopapillary neoplasms (3 cases) and 1 case had anaplastic.Table 1Literature review of 41 cases.Table 1AuthorHistologyPatient ageClinical presentationGestation at presentation (trimester/ weeks)Diagnosis methodGestation for Surgery (trimester/ weeks)ComplicationsSmithers et al. \[[@bib0060]\]MCN----1st (7)--1 st (8)Tumor rupturedBaiocchi et al. \[[@bib0065]\]MCN----3rd--PostpartumNone reportedPorcel et al. \[[@bib0030]\]Adenocarcinoma43epigastric pain,\
Upper lumbar backache, nausea and vomiting.3rd (28)Aspiration cytology--severe pre-eclampsia, HELLP syndrome, left axillar venous thrombosis, Pancreatic metastasis\
Mother death 35 days post-partumOlsen et al. \[[@bib0070]\]MCN----1st (6)--2nd (18)None reportedSimchuk et al. \[[@bib0075]\]Adenocarcinoma----2nd (16)--2nd (16)metastasesSciscione et al. \[[@bib0080]\]Neuroendocrine37Incidentally US finding (pancreatic mass)2nd (19)--2nd (20)Fetal deathBlackbourne et al. \[[@bib0085]\]Adenocarcinoma32back pain, nausea, emesis, and dark urine2nd (14)Intraoperative FNA2nd (17)No complicationsGanepola et al. \[[@bib0090]\]MCN37Abdominal pain1st (4)Frozen section2nd (23)No complicationsLopez-Tomassetti et al. \[[@bib0095]\]MCN26abdominal\
pain and hyperemesis2nd (20)Histological analysis of resected mass2nd (20)No complicationsKato et al. \[[@bib0100]\]MCN33abdominal distention2nd (15)MRI- Intraoperative ultrasound2nd (20)Pre-op IUGRMarinoni et al. \[[@bib0040]\]Adenocarcinoma38Epigastric pain3rd (27)Biopsy by ERCPPostpartumMother death 50 days post-partumLin Lin Su et al. \[[@bib0105]\]Adenocarcinoma37intermittent epigastric pain2nd (22)Ultrasound-guided liver biopsy\
confirmed metastatic poorly differentiated adenocarcinoma,\
Consistent with a pancreatic primary.2ndTermination of pregnancyIshikawa et al. \[[@bib0110]\]MCN33Epigastric mass2nd (17)MRIPostpartumNo complicationsAl Adnani et al. \[[@bib0115]\]Adenocarcinoma27Prenatal care: HTN, fallen fetal growth3rd (30)Pancreatic biopsy--IUGR, placental metastasis,\
Mother death 3 moths postpartumHerring et al. \[[@bib0120]\]MCN34Accidental finding of abdominal mass during routine follow up1st (3)Histological analysis of resected mass2nd (17)No complicationsOzden et al. \[[@bib0125]\]MCN32Epigastric pain3rd (36)Histological analysis of resected mass3rd (36)Tumor ruptureWiseman et al. \[[@bib0130]\]MCN32LUQ pain with palpable mass2nd (15)MRI- US guided drainage2nd (16)Pre-op Intractable nauseaHakamada et al. \[[@bib0135]\]Anaplastic38Incidentally US finding1st trimester, 1st pregnancyMRI- US2nd trimester, 2nd pregnancyIntractable nausea, upper GI bleed (pre-op), local recurrence (post-op)Ikuta et al. \[[@bib0140]\]MCN30Left hypochondrial pain1st (10)CT, - US guided drainagePost-abortionMissed abortionKamphues et al. \[[@bib0145]\]Neuroendocrine32Arterial HTN2nd (19)US, MRI2nd (19)Splenic vein thrombosis renal artery compression (intra-op)Kamphues et al. \[[@bib0145]\]Neuroendocrine35Vomiting, weight loss2nd (16)Needle biopsy2nd (18)No complicationsKakoza et al. \[[@bib0055]\]Adenocarcinoma40Epigastric pain, nausea, vomiting2nd (24)Duodenal mucosal biopsyPostpartumLiver metastasis, mother death 6 months post-opAsciutti et al. \[[@bib0150]\]MCNEpigastric pain + mass2nd (23)--PostpartumPancreatitisOnuma et al. \[[@bib0155]\]Adenocarcinoma32frequent uterine\
contractions3rd (30)CT, Histological analysis of resected mass3rd (34)Pre-op Gastric perforationNaganuma et al. \[[@bib0160]\]MCN32threat of premature labor3rd (33)CT, Histological analysis of resected mass3rd (34)Tumor rupture, local recurrence 6 months pos-opPerera et al. \[[@bib0035]\]Adenocarcinoma25Epigastric pain, nausea,\
One episode of emesis2nd (20)MRCP, ERCPNo surgery, underwent chemotherapyMother DeathLubner et al. \[[@bib0165]\]Adenocarcinoma37nausea, vomiting,\
back pain, acholia, and dark colored urine2nd (16)EUS with FNA2nd (18)Death 12 months post diagnosisMarci et al. \[[@bib0170]\]Adenocarcinoma36Epigastric pain, vomiting, weight loss3rd (35)US, CTPostpartum(PRE-OP) Acute renal failureFeng et al. \[[@bib0175]\]SPNs26Incidentally abdominal mass by US2nd (14)US, MRI, needle biopsy2nd (14)3rd postoperative day pancreatic fistula occurredBoyd et al. \[[@bib0180]\]MCN21abdominal distention and fullness1st (10)CT, MRI2nd (20)No complicationsBoyd et al. \[[@bib0180]\]Adenocarcinoma29Emesis, epigastric pain3rd (37)US, CTPostpartum2 weeks post-op PE, iliac & femoral veins thrombosis, DIC, multiorgan system failure & death.Boyd et al. \[[@bib0180]\]Adenocarcinoma37right upper back pain, nausea and vomiting, alcoholic stools, and dark urine2nd (17)US, ERCP, FNA2nd (19)4 months post-op liver metastasis, 1-year post-op death.Liu et al. \[[@bib0185]\]Adenocarcinoma31weight loss and progressive, positional dyspnea3rd trimesterUS, CT, PET scan3rd (34)Ovarian cyst rupture,\
(post-op) Pleural effusion, ascitesTsuda et al. \[[@bib0190]\]MCN28Referred as case of abdominal tumor1st (9)US, MRI,2nd (18)Mild glucose intolerance post-op.Tica et al. \[[@bib0195]\]MCN27abnormal sonogram3rd (29)MRIpostpartumNo complicationsHuang et al. \[[@bib0200]\]SPNs29Epigastric pain, backache, nausea, and vomiting2nd (19)US, MRI2nd (19)Tumor ruptureMacDonald et al. \[[@bib0205]\]SPNs23Incidentally abdominal mass by US2nd (14)US, MRI2nd (18)No complicationsLabarca-Acosta et al. \[[@bib0210]\]Adenocarcinoma35Vomiting, pain in the left epigastrium and hypochondrium, general weakness and weight loss.16 weeksFine-needle biopsy--Maternal deathAker et al. \[[@bib0215]\]Adenocarcinoma27Right upper quadrant pain, nausea,and vomiting.2nd (26)ascites cytologyPost-partumFetal death\
Metastasis to placenta, hepatic, supraclavicular lymph nodeDavis et al. \[[@bib0220]\]Adenocarcinoma34abdominal pain and failure to gain weight appropriately in pregnancy.2nd (26)Pathology\
on fine-needle aspiration of the pancreatic head mass confirmed\
pancreatic adenocarcinoma--Death 4 months after C-sectionAynioglu et al. \[[@bib0225]\]Adenocarcinoma36recurrent severe abdominal pain radiating to the back, jaundice,\
nausea, and vomiting.3rd (28)Histopathological analysisPost-partumNo complication[^1]

In case of pregnancy, diagnosing of ampullary adenocarcinoma can be challenging. The way it does that is by making alarming symptoms of malignancy through the physiological changes of pregnancy. As jaundice can develop frequently in the 3rd trimester due to benign intrahepatic cholestasis, which can be misleading initially as in our case. Furthermore, other symptoms that adenocarcinoma of ampulla of Vater cause like abdominal discomfort, nausea & vomiting also can happen in normal pregnancy. Another challenge is that the gravid uterus that decreases the sensitivity of non-invasive imaging modalities \[[@bib0025]\]. The reported cases demonstrate a variety of gestational ages at presentation, which indicated a clinical difficulty in diagnosis. Unlike our case, most of the reported cases presented at 2nd trimester.

There are different radiological modalities that can aid in obtaining a confirmatory diagnosis and staging of ampullary carcinoma but not all of these can be used freely during pregnancy such as ERCP or CT scan, due to the risk of radiation exposure to the fetus \[[@bib0035]\]. The main diagnostic modalities for pregnant women are ultrasonography and MRCP. The ultrasonography is mainly used to identify the presence of biliary dilation & obstruction while MRCP can visualize the mass \[[@bib0040]\].

In our case, the MRCP revealed an ampullary mass measuring 2 cm with no vascular involvement. ERCP is used during pregnancy for diagnosis by obtaining a biopsy, stenting for biliary draining and to prepare the patient for surgery or if the tumor is not operable. To minimize the risk radiation exposure to the fetus the patient should have a lead shield in place as we did in our case. Biochemically, an elevated carbohydrate antigen 19-9 (CA 19-9) level may help to guide the diagnosis towards an ampullary adenocarcinoma \[[@bib0020]\]. Nevertheless, US and MRCP were the main diagnostic modalities reported in the literature.

Management wise, surgical resection is usually done by a Whipple procedure (Pancreaticoduodenectomy) followed by an adjuvant therapy is the standard of care for early stage disease. Such surgery carries a risk of many complications. One important complication to consider is pancreatic fistula or leak with a reported incidence ranging from 2 to 40% \[[@bib0045]\].

To decrease the risk of such complication, intraoperatively a pancreatic duct stent can be used. Adaptation of this technique to protect the anastomotic site & decrease the chance of any leak have led good to outcome of such procedure in some centers \[[@bib0050]\].

Surgical intervention is challenging in pregnant patients, the appropriate time to intervene depends on the gestational age at the time of diagnosis and the stage of the disease. The challenges that might be encountered in first trimester, is the risk of spontaneous abortion and the best strategy is to abort the pregnancy. While in the second trimester induced delivery can't be applied as gestational age is not compatible with life and it is the most dangerous time to put the patient on chemotherapy. In the third trimester, the large size of the uterus is another challenge especially intraoperatively \[[@bib0055]\].

In our patient, the obstetrician induced labor at week 34 of gestation & Whipple procedure was done afterwards and the major challenge was a presence of a bulky uterus during the surgery.

4. Conclusion {#sec0020}
=============

Obtaining a diagnosis of ampullary adenocarcinoma in pregnant patients in their third trimester & managing them can be challenging due to; 1) the overlapping symptoms between it & the physiological changes of pregnancy, 2) the limitation of using the appropriate diagnostic modalities in order to avoid radiation exposure to the fetus, 3) the intraoperative technical difficulties 2ry to the gravid uterus. Yet, a delayed viable delivery followed by a definitive surgery in the form of pancreaticoduodenectomy is still achievable with a multi-disciplinary approach & good perioperative preparation in early stage disease.
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[^1]: MCN = mucinous cystic neoplasm; HELLP = hemolysis& elevated liver enzymes level and low platelet; IUGR = intrauterine growth restriction; SPNs = Solid-pseudo papillary neoplasms.
